PCML Continues Partnership with One Nucleus

Cambridge UK:  December 2022

PCML Group continues partnership with One Nucleus to develop engagement with One Nucleus and its members. The One Nucleus Partner Programme is tailor-made to meet the needs of the Partner and One Nucleus members.

Lee Carlin, Commercial Director of the PCML Group: ‘Following our successful collaboration with One Nucleus in 2022, we hope that our continued partnership will deepen our understanding of the challenges faced in the development and manufacture of Life Science and Biomedical technology and we can continue to support members within the One Nucleus community’.

Tony Jones, CEO of One Nucleus expands further: ‘We are delighted to continue our partnership with PCML. Over the past year, PCML have collaborated with One Nucleus on webinars, demonstrating the expertise they bring to the network. This included an insightful discussion around making the transition from prototype to product as well as engaging with the wider Life Science network via One Nucleus conferences. Their participation is valuable for enabling cross-sector engagement which is increasingly shaping and influencing the Life Science sector. One Nucleus is proud to support this interaction and we are looking forward to developing this Partnership further to bring more support to the One Nucleus community to help solve common challenges’.

Media Contact Information: